EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 208 filers reported holding EXELIXIS INC in Q3 2016. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $2,371,000 | -2.4% | 97,854 | -0.8% | 0.01% | -6.7% |
Q2 2017 | $2,429,000 | +14.6% | 98,601 | +0.8% | 0.02% | +7.1% |
Q1 2017 | $2,120,000 | +295.5% | 97,809 | +172.0% | 0.01% | +250.0% |
Q4 2016 | $536,000 | +2.7% | 35,954 | -11.8% | 0.00% | 0.0% |
Q3 2016 | $522,000 | +53.1% | 40,779 | -6.6% | 0.00% | +33.3% |
Q2 2016 | $341,000 | +105.4% | 43,669 | +5.5% | 0.00% | +200.0% |
Q1 2016 | $166,000 | -32.2% | 41,394 | -4.8% | 0.00% | -50.0% |
Q4 2015 | $245,000 | +1.2% | 43,497 | +0.9% | 0.00% | -33.3% |
Q3 2015 | $242,000 | +68.1% | 43,095 | +12.7% | 0.00% | +200.0% |
Q2 2015 | $144,000 | +42.6% | 38,236 | -2.4% | 0.00% | 0.0% |
Q1 2015 | $101,000 | +106.1% | 39,186 | +14.0% | 0.00% | 0.0% |
Q4 2014 | $49,000 | -5.8% | 34,360 | +1.3% | 0.00% | 0.0% |
Q3 2014 | $52,000 | -17.5% | 33,910 | +82.2% | 0.00% | 0.0% |
Q2 2014 | $63,000 | -33.7% | 18,615 | -30.6% | 0.00% | 0.0% |
Q1 2014 | $95,000 | -33.1% | 26,815 | +15.5% | 0.00% | -50.0% |
Q4 2013 | $142,000 | -2.1% | 23,215 | -6.9% | 0.00% | 0.0% |
Q3 2013 | $145,000 | – | 24,941 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
AJO, LP | 7,636,882 | $134,561,000 | 0.80% |